Biotech Values

[urche]

Question on Pharming

Pharming also plans to file for market approval for the C1 inhibitor with the U.S. Food and Drug Administration.

I haven't looked at the Pharming data, but does it meet the standard for FDA approval---usually two controlled trials? In this case, I would think that the double blind randomized criteria could be dropped.

urche